ROYALTY PHARMA PLC- CL A (RPRX)
GB00BMVP7Y09 - Common Stock
NASDAQ:RPRX: good value for what you're paying.
Investors should take notice ofROYALTY PHARMA PLC- CL A (NASDAQ:RPRX)—it offers a great deal for the fundamentals it presents.
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2024 financial...
Royalty Pharma Declares Second Quarter 2024 Dividend
Royalty Pharma Declares Second Quarter 2024 Dividend
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the...
Relative Strength Alert For Royalty Pharma
3 Pharma Stocks to Sell in April Before They Crash & Burn
Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside.
Billionaire Bargain Bin: 3 Stocks the Forbes 400 Loves (That You’ve Never Heard Of)
These Forbes 400 stocks have wealthy founders who run them with little fanfare or attention but are worth considering for your portfolio.
April’s Hidden Gems: 3 Overlooked Stocks to Freshen Up Your Portfolio
Discover three overlooked stocks on Wall Street with the potential for growth and diversification this April.
January 2025 Options Now Available For Royalty Pharma (RPRX)
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
With a possible rotation away from the technology space, these are the undervalued healthcare stocks to consider.
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s...
Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 Months
Analysts are quite bullish about these beaten-down stocks.
Royalty Pharma reports Q4 results (NASDAQ:RPRX)
Royalty Pharma press release (RPRX): Q4 net income of $718M Revenue of $596M (+5.3% Y/Y) misses by $78.54M. More on Royalty Pharma Royalty Pharma: One Of The Be
Royalty Pharma Reports Q4 and Full Year 2023 Results
Royalty Pharma Reports Q4 and Full Year 2023 Results
Portfolio Receipts of $736 million in Q4 2023 and $3,049 million for FY 2023Net cash provided by operating activities of $773 million in Q4 2023 and $2,988...
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
These are the biotech stocks to buy that you must have on your watchlist for the coming bull run. It could get started as soon as this month.
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter and full year 2023...
Royalty Pharma raises dividend by 5% (NASDAQ:RPRX)
Royalty Pharma (RPRX) announced a 5% increase in its quarterly dividend to $0.21/share.
Royalty Pharma Announces Dividend Increase
Royalty Pharma Announces Dividend Increase
NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the...
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
First Week of February 2024 Options Trading For Royalty Pharma (RPRX)
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at...